| Literature DB >> 32290080 |
Qianqian Pang1, Xueqin Chen1, Jinhua Lv1, Teng Li1, Jinggui Fang1, Haifeng Jia1.
Abstract
Triacontanol (TA) is a non-toxic, pollution-free, low-cost, high-efficiency, broad-spectrum plant growth regulator that plays an important role in plant growth and development, but its regulation mechanism of strawberry (Sweet charlie, Fragaria × ananassa Duch.) fruit development is still unclear. In this study, we showed that TA treatment (50 μM) could promote fruit development by up-regulating factors related to fruit ripening-related growth and development. TA increased fruit sugar content and anthocyanin accumulation, and many stress-related enzyme activities. In the meantime, Illumina RNA-Seq technology was used to evaluate the effect of TA treatment on strawberry fruit senescence. The results showed that 9338 differentially expressed genes (DEGs) were obtained, including 4520 up-regulated DEGs and 4818 down-regulated DEGs. We performed gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of these DEGs. The results showed that TA treatment caused changes in transcript levels related to cellular processes, hormones and secondary metabolism, such as DNA metabolic processes, flavonoid synthesis, and plant hormone signal transduction. Bioinformatics analysis showed that many transcription factors were related to fruit maturity. Taken together, this study will provide new insights into the mechanism of strawberry development and postharvest response to TA treatment.Entities:
Keywords: development; senescence; strawberry; transcriptome; triacontanol
Year: 2020 PMID: 32290080 PMCID: PMC7238246 DOI: 10.3390/plants9040488
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Effects of triacontanol on strawberry fruit ripening. (A). Fruit number. (B). Anthocyanin content. (C). Chlorophyll content. (D). VC (vitamin C) content. (E). TSS % (total soluble solid). (F). Sugar content. (G). Firmness. (H). TA %. (I). ABA (abscisic acid) content. (J). IAA (indoleacetic acid) content. (K). Ethylene content. (L). Protein content. Control: CK; TA: triacontanol. Vertical bars represented standard deviations (SD) of means (n = 3). Asterisks indicated statistically significant differences at p < 0.05 as determined by Student’s t-test.
Figure 2Effects of triacontanol on sugar metabolism. Enzyme activities of (A). α-amylase. (B). β-amylase. (C). AGPase. (D). Relative gene expression. (E). Dry weight rate%. Vertical bars represented standard deviations (SD) of means (n = 3). Asterisks indicated statistically significant differences at p < 0.05 as determined by Student’s t-test.
Figure 3Effects of triacontanol on strawberry fruit stress resistance. (A). Number of flowers. (B). Number of buds. (C). Inflorescence length. Enzyme activities of (D). SOD (superoxide dismutase). (E). POD (peroxidase). (F). CAT (catalase). (G). PPO (polyphenol oxidase). (H). Proline. (I). MDA (malondialdehyde). (J). Relative gene expression. Vertical bars represented standard deviations (SD) of means (n = 3). Asterisks indicated statistically significant differences at p < 0.05 as determined by Student’s t-test.
Figure 4Different treatment samples analysis. (A). The calculation of expression level in strawberry fruit under TA (triacontanol) treatment. A total of 108,087 genes were identified and the number of genes in different sections were similar among both control and TA-treated. (B). Correlation matrix showed the correlation between samples. Both the CK (control) and TA-treated had the darkest colors, indicating that the correlation between the same treatment samples was the highest. (C). Principal Component Analysis (PCA) were performed on the biological replicates of each sample set (CK and TA), which the same treatment samples were closed, indicating the higher similarity between samples.
Figure 5Classification analysis of differentially expressed genes. (A). Volcano map displayed the relation between log 2 (Fold Change) and -log 10 (p-value), which more obviously showed the diversity expression of up-regulated and down-regulated DEGs (differentially expressed genes). The blue color on the figure were down-regulated genes, the red were up-regulated genes and the grey color in the middle were the genes have no difference. (B). Clusters of differentially expressed genes in the control and TA-treated groups. Genes were shown horizontally, and each column was a sample. The red was highly expressed genes and green was low expressed genes.
Figure 6Enrichment analysis of differentially expressed genes. (A). The top ten significant enrichment GO term in biological process (BP), molecular function (MF) and cellular component (CC). The abscissa was the logarithm of the significant enrichment P value with the base 10, and the ordinate was the gene ID. (B). Top 20 KEGG enrichment pathways by FDR. Rich Factor was the ratio of the differentially expressed number of genes located in the pathway. The higher the Rich Factor, the higher the degree of enrichment. FDR was false discovery rate in the range of 0 to 1, the closer to zero, the more significant the enrichment.
Differentially expressed genes in antioxidant enzymes.
| Genes | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| SOD | 5 | 0 | 5 |
| CAT | 1 | 0 | 1 |
| POD | 14 | 8 | 22 |
| PPO | 1 | 5 | 6 |
Note: SOD, superoxide dismutase; CAT, catalase isozyme 1; POD, peroxidase; PPO, polyphenol oxidase.
Changes in cell wall softening-related enzyme genes under TA treatmen.
| Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| Cx | 1 | 6 | 7 |
| α-Af | 0 | 3 | 3 |
| PE | 9 | 23 | 32 |
| PG | 10 | 5 | 15 |
| PL | 3 | 3 | 6 |
| β-Gal | 7 | 6 | 13 |
| EXP | 8 | 13 | 21 |
| XET | 16 | 3 | 19 |
Note: Cx, cellulase; α-Af, alpha-L-arabinofuranosidase; PE, pectinesterase; PG, polygalacturonase; PL, pectate lyase; β-Gal, beta-galactosidase; EXP, expansin; XET, xyloglucosyl transferase.
Differential expression genes related to Porphyrin and chlorophyll metabolism under TA treatment.
| Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| HemL | 0 | 1 | 1 |
| HMBS | 1 | 0 | 1 |
| UROD | 3 | 0 | 3 |
| PPOX | 2 | 0 | 2 |
| CPOX | 1 | 0 | 1 |
| chlD | 1 | 0 | 1 |
| chlI | 3 | 0 | 3 |
| chlM | 2 | 0 | 2 |
| DVR | 1 | 0 | 1 |
| FECH | 2 | 2 | 4 |
| HMOX1 | 1 | 1 | 2 |
| HY2 | 4 | 0 | 4 |
| chlG | 1 | 0 | 1 |
| CAO | 1 | 0 | 1 |
| HCAR | 1 | 0 | 1 |
| NOL, NYC1 | 2 | 0 | 2 |
| chlP | 2 | 0 | 2 |
Note: HemL, glutamate-1-semialdehyde 2, 1-aminomutase; HMBS, hydroxymethylbilane synthase; UROD, uroporphyrinogen decarboxylase; PPOX, protoporphyrinogen/coproporphyrinogen III oxidase; CPOX, coproporphyrinogen III oxidase; chlD, magnesium chelatase subunit D; chlI, magnesium chelatase subunit I; chlM, magnesium-protoporphyrin O-methyltransferase; DVR, divinyl chlorophyllide a 8-vinyl-reductase; FECH, protoporphyrin/coproporphyrin ferrochelatase; HMOX1, heme oxygenase 1; HY2, phytochromobilin:ferredoxin oxidoreductase; chlG, chlorophyll/bacteriochlorophyll a synthase; CAO, chlorophyllide a oxygenase; HCAR, 7-hydroxymethyl chlorophyll a reductase; NOL, NYC1, chlorophyll(ide) b reductase; chlP, geranylgeranyl diphosphate/geranylgeranyl-bacteriochlorophyllide a reductase.
Differential expression genes related to Carotenoid biosynthesis under TA treatment.
| Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| PSY | 0 | 2 | 2 |
| crtISO | 2 | 0 | 2 |
| CrtR-b | 1 | 0 | 1 |
| VDE | 0 | 1 | 1 |
| CCS1 | 0 | 1 | 1 |
| NCED | 0 | 7 | 7 |
| AAO3 | 2 | 0 | 2 |
| CYP707A | 3 | 3 | 6 |
| AOG | 1 | 0 | 1 |
Note: PSY, phytoene synthase; crtISO, prolycopene isomerase; CrtR-b, beta-carotene 3-hydroxylase; VDE, violaxanthin de-epoxidase; CCS1, capsanthin/capsorubin synthase; NCED, 9-cis-epoxycarotenoid dioxygenase; AAO3, abscisic-aldehyde oxidase; CYP707A, (+)-abscisic acid 8’-hydroxylase; AOG, abscisate beta-glucosyltransferase.
Differential expression genes related to anthocyanins metabolism under TA treatment.
| Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| PAL1 | 0 | 8 | 8 |
| CCoAOMT | 1 | 0 | 1 |
| CYP73A | 0 | 4 | 4 |
| CHS | 0 | 7 | 7 |
| HCT | 0 | 5 | 5 |
| C3’H | 0 | 1 | 1 |
| CHI | 0 | 3 | 3 |
| DFR | 0 | 4 | 4 |
| F3H | 0 | 3 | 3 |
| ANS | 0 | 3 | 3 |
| LAR | 0 | 4 | 4 |
| UFGT | 5 | 6 | 11 |
Note: PAL1, phenylalanine ammonia-lyase 1; CCoAOMT, caffeoyl-CoA O-methyltransferase; CYP73A, trans-cinnamate 4-monooxygenase; CHS, chalcone synthase; HCT, shikimate O-hydroxycinnamoyltransferase; C3’H, 5-O-(4-coumaroyl)-D-quinate 3’-monooxygenase; CHI, chalcone isomerase; DFR, bifunctional dihydroflavonol 4-reductase/flavanone 4-reductase; F3H, naringenin 3-dioxygenase; ANS, anthocyanidin synthase; LAR, leucoanthocyanidin reductase; ANR, anthocyanidin reductase; UFGT, UDP-glucose flavonoid 3-O-glucosyltransferase.
Differentially expressed genes of eight plant hormone synthesis and signal transduction.
| Pathway | Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|---|
| IAA biosynthesis | TAR | 3 | 3 | 6 |
| Auxin signal transduction | AUX1 | 0 | 1 | 1 |
| TIR1 | 0 | 2 | 2 | |
| AUX/IAA | 9 | 4 | 13 | |
| ARF | 0 | 1 | 1 | |
| GH3 | 6 | 3 | 9 | |
| SAUR | 8 | 5 | 13 | |
| CTK signal transduction | CRE1 | 0 | 2 | 2 |
| AHP | 0 | 1 | 1 | |
| B-ARR | 3 | 1 | 4 | |
| A-ARR | 5 | 1 | 6 | |
| GA signal transduction | PIF4 | 0 | 2 | 2 |
| ABA biosynthesis | SDR | 3 | 0 | 3 |
| AAO3 | 2 | 0 | 2 | |
| ABA signal transduction | PYR/PYL | 1 | 8 | 9 |
| PP2C | 5 | 1 | 6 | |
| SnRK2 | 3 | 2 | 5 | |
| ABF | 0 | 1 | 1 | |
| ETH biosynthesis | ACO | 4 | 5 | 9 |
| ACS | 0 | 4 | 4 | |
| ETH signal transduction | ETR | 0 | 4 | 4 |
| SIMKK | 0 | 2 | 2 | |
| MPK6 | 2 | 0 | 2 | |
| EIN2 | 2 | 0 | 2 | |
| EIN3 | 0 | 3 | 3 | |
| EBF1/2 | 0 | 1 | 1 | |
| ERF1/2 | 0 | 6 | 6 | |
| BR signal transduction | BKI1 | 3 | 0 | 3 |
| BSK | 4 | 3 | 7 | |
| CYCD3 | 1 | 3 | 4 | |
| JA signal transduction | JAR1 | 1 | 0 | 1 |
| COI1 | 0 | 1 | 1 | |
| JAZ | 4 | 6 | 10 | |
| SA signal transduction | TGA | 4 | 8 | 12 |
Note: TAR, tryptophan aminotransferase-related protein; AUX1, auxin influx carrier; AUX/IAA, auxin-responsive protein IAA; TIR1, transport inhibitor response 1; ARF, auxin response factor; GH3, auxin responsive GH3 gene family; SAUR, SAUR family protein; CRE1, histidine kinase(cytokinin receptor); AHP, histidine-containing phosphotransfer peotein; B-ARR, two-component response regulator ARR-B family; A-ARR, two-component response regulator ARR-A family; PIF4, phytochrome-interacting factor 4; SDR, short-chain type dehydrogenase/reductase; AAO3, abscisic-aldehyde oxidase; PYR/PYL, abscisic acid receptor PYR/PYL family; PP2C, protein phosphatase 2C; SnRK2, serine/threonine-protein kinase SRK2; ABF, ABA responsive element binding factor; ACO, 1-aminocyclopropane-1-carboxylic acid oxidase; ACS,1-aminocyclopropane-1-carboxylate synthase; ETR, ethylene receptor; SIMKK, mitogen-activated protein kinase kinase 4/5; MPK6, mitogen-activated protein kinase 6; EIN2, ethylene-insensitive protein 2; EIN3, ethylene-insensitive protein 3; EBF1/2, EIN3-binding F-box protein; ERF1/2, ethylene-responsive transcription factor 1; BKI1, BRI1 kinase inhibitor 1; BSK, BR-signaling kinase; CYCD3, cyclin D3; JAR1, jasmonic acid-amino synthetase; COI1, coronatine-insensitive protein 1; JAZ, jasmonate ZIM domain-containing protein; TGA, transcription factor TGA.
Differential expression genes related to starch and sucrose metabolism.
| Gene | No. of Up-Regulated | No. of Down-Regulated | Sum |
|---|---|---|---|
| HK | 1 | 0 | 1 |
| SS | 8 | 0 | 8 |
| SSY | 2 | 0 | 2 |
| GBSS | 3 | 0 | 3 |
| PYG | 2 | 0 | 2 |
| GBE1 | 5 | 0 | 5 |
| TREH | 1 | 0 | 1 |
| INV | 0 | 3 | 3 |
| EGs | 0 | 6 | 6 |
| UGP2 | 0 | 1 | 1 |
| glgC | 0 | 1 | 1 |
| bgl | 4 | 9 | 13 |
| GN1_2_3 | 3 | 1 | 4 |
| GN5_6 | 1 | 0 | 1 |
| SPS | 1 | 2 | 3 |
| TPS | 1 | 5 | 6 |
| TPP | 6 | 3 | 9 |
| BAM | 6 | 1 | 7 |
Note: HK, hexokinase; SS, sucrose synthase; SSY, starch synthase; GBSS, granule-bound starch synthase; PYG, glycogen phosphorylase; GBE1, 1,4-alpha-glucan branching enzyme; TREH, alpha, alpha-trehalase; INV, beta-fructofuranosidase; EGs, endoglucanase; UGP2, UTP-glucose-1-phosphate uridylyltransferase; glgC, glucose-1-phosphate adenylyltransferase; bgl, beta-glucosidase; GN1_2_3, glucan endo-1,3-beta-glucosidase 1/2/3; GN5_6, glucan endo-1,3-beta-glucosidase 5/6; SPS, sucrose-phosphate synthase; TPS, trehalose 6-phosphate synthase/phosphatase; TPP, trehalose 6-phosphate phosphatase; BAM, beta-amylase.